Nerivio Wearable Migraine Therapeutic Now Eligible for Insurance Coverage through UpScript’s Telemedicine Platform

April 12, 2021

Nerivio (FDA-authorized) prescribed wearable for the acute treatment of migraine is now eligible for insurance coverage through the UpScript direct-to-patient telemedicine platform.

“It is our mission to make Nerivio accessible to everyone who experiences migraine episodes,” said Theranica CEO Alon Ironi. “We appreciate the efforts UpScript made to make Nerivio available and covered through its advanced telemedicine platform.

People with migraine need rapid, affordable access to safe and effective therapies, and this is exactly what they can get using UpScript. This service connects any patient with a trained healthcare provider and, if they secure a prescription, a quick path to receiving their device, anywhere in the United States.”

Nerivio’s list price (Wholesale Acquisition Price, or WAC) is $599 for a 12-treatment unit. The Nerivio Patient Savings Program and reimbursement hub implementation enables Theranica to offer eligible patients with health insurance a co-pay as low as $10, depending on specific plan coverage. Nerivio is also covered by United States Veterans Administration (VA) system health insurance.

“At UpScript, we are pleased to be providing US patients the opportunity to try Nerivio, a unique prescribed therapeutics device which is now available for reimbursement,” added UpScript CEO Peter Ax. “We believe this is a unique way for migraine headache patients to try a great device in a convenient, affordable way through a telemedicine visit on the UpScript platform.”

SourceTheranica
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

“It’s exciting to be one of the first two hospitals in Europe to use Stryker’s Mixed Reality Guidance System,” said Professor Berhouet. “I am also pleased to be leading a pilot study to investigate the safety and effectiveness of this new technology, alongside three other centres in France.”
The KnowU incorporates the sensor that the Company plans to submit to the FDA for clearance. This proprietary sensor has been tested and proven stable and accurate in the lab setting. It was included in the Company’s prototype to validate stability outside of the lab, and is now miniaturized and wearable.
The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy